The Daily Dive

Earlier this year, America was running low on a crucial resource for coronavirus vaccines and drugs…monkeys. The pandemic has created a huge demand for monkeys as research test subjects. There has been a drop in supply from China which supplied 60% of monkeys imported into the U.S., and we were already dealing with decreased numbers. Sarah Zhang, writer at the Atlantic, joins us for how were are s...

The coronavirus is mutating, and while we should be cautious, there is no cause for alarm yet. A new variant of the virus has appeared in the U.K. that officials said could spread up to 70% faster, but luckily, the variant doesn’t seem to be any more severe. Some have expressed concern that it might become resistant to the current vaccines rolling out. The worries are focused on whether the new st...

A CDC panel over the weekend has made its recommendations on who is next in line to receive the two vaccines we have available so far. What is called Phase 1b, will see first responders such as police and firefighters, other frontline workers like teachers and grocery workers and also people over 75 get the vaccine. Karen Weintraub, health reporter at USA Today, joins us for who’s next in getting...

Democrats and Republicans have reached a compromise deal on a new coronavirus stimulus package that will give Americans a direct payment of $600 and enhanced unemployment benefits of $300 per week. In other news, President Trump has been downplaying the seriousness of the hack of several government agencies saying it could have been China despite experts and even Mike Pompeo saying it was clearly...

This is a compilation of some of the most compelling stories of the week. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com See omnystudio.com/listener for privacy information.

This is a compilation of some of the most compelling stories of the week. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com See omnystudio.com/listener for privacy information.

The pandemic has accelerated the exit of many Americans from big cities and tax heavy states to cheaper ones that can provide lower costs, bigger living spaces, and a better quality of life. New York and California have seen a big exodus and people are moving to places like Texas and Florida. Austin, gained the most people between April and October this year. Misyrlena Egkolfopoulou, reporter at B...

The U.S. has been hacked again. Russian government hackers are believed to be responsible for infiltrating the computer systems of multiple agencies including the Pentagon, Homeland Security, Treasury Department, and even the National Institutes of Health. The hacking group, Cozy Bear are said to be the perpetrators and exploited a vulnerability in computer monitoring software from a company calle...

We are on track to get the second coronavirus vaccine approved by the end of the week. On Tuesday, the FDA confirmed that Moderna’s two-dose vaccine is safe and effective. In the first week of its rollout about 6 million doses will be shipped out. The government also bought another 100 million doses from Moderna for a total of 200 million at a cost of $3.2 billion. Sarah Owermohle, health care rep...

The worst fears of public health experts came true after Thanksgiving travel… rising Covid cases, reduced ICU bed capacity, and more lockdowns. Even though vaccines are currently rolling out, health officials are worried about Christmas and New Year’s celebrations. They are already urging caution about traveling, but as we saw already, many people will probably not follow that advice. There were s...

The Pfizer vaccine is being shipped out now to all the states and will start being administered immediately as we mark another turn in the pandemic. Despite President Trump's record on handling the coronavirus, Operation Warp Speed has been a success in getting a vaccine approved in less than a year. In other news, after suffering another loss in court, it seems that the president is all out of op...

This is a compilation of some of the most compelling stories of the week. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com See omnystudio.com/listener for privacy information.

This is a compilation of some of the most compelling stories of the week. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com See omnystudio.com/listener for privacy information.

An FDA advisory committee has recommended authorization of the Pfizer vaccine and it will soon start making its way through the U.S., but some of the biggest hurdles still to overcome are mistrust in both the government and vaccines themselves. Polls are showing that many still do not want to take the vaccine as soon as it is available. This is especially evident in communities of color who are di...

As we wait for the emergency use authorization here in the U.S. for the Pfizer vaccine, all eyes are on the U.K. with their program and many were alarmed when two British people had allergic reactions to the vaccine. It prompted British officials to advise those with serious allergies to avoid getting vaccinated for now. Karen Weintraub, health reporter at USA Today, joins us for the latest as the...

The U.K. has begun the rollout of the Pfizer vaccine and all eyes will be on them for things they do right and things they get wrong. It has been less than a week that Britain has granted emergency use authorization and because of limited supplies and how difficult the Pfizer vaccine is to ship and store, only about 50 hospital hubs will be able to administer the vaccine for now. Joanna Sugden, as...

Reports are saying that Attorney General Bill Barr is considering leaving his post before the end of President Trump's term. Trump continues to dispute the outcome of the election even as the Department of Justice has said that there was no widespread fraud, which has put Barr at odds with the president. Devlin Barrett, national security reporter at The Washington Post, joins us for what might be...

President Trump continued to dispute the outcome of the election at a rally in Georgia over the weekend while he also encouraged his followers to vote in the Senate runoff election there. Some experts say that while Trump's claims of fraud won't work in court, it could lay the groundwork for new voting restrictions. Joe Biden in the meantime, continues the transition and will meet with Operation W...

This is a compilation of some of the most compelling stories of the week. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com See omnystudio.com/listener for privacy information.

This is a compilation of some of the most compelling stories of the week. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com See omnystudio.com/listener for privacy information.

We are seeing coronavirus continue to spread across the country, hospitalizations and deaths are also on the uptick and doctors and nurses are caught in the middle with treating the sick and people who still think the virus isn’t as bad as some make it seem. Some health-care workers call it “Covid denial,” and on top of the physical and mental demands of the job, they say this makes it harder for...

Lots of news out of the CDC recently when it comes to COVID-19. First, the CDC said that the standard 14 day quarantine can be shortened to 10 days or even seven if certain criteria are met. It can be 10 days if you are showing no symptoms at all, and seven if you get a negative test. New guidelines were also released when it comes to testing before and after travel. Joel Achenbach, science report...

The airline industry has taken a huge hit during the pandemic and some of the declines could be permanent. A new analysis says that business travel could be permanently cut by 36% and that could also affect the way you travel. Regular consumers could see higher ticket prices and reduced routes to your favorite places. Scott McCartney, Middle Seat columnist at the WSJ, joins us for more. Next, a bi...

Moderna has now become the second company to request emergency use authorization from the FDA for their vaccine candidate. In their latest findings, the vaccine is over 94% effective against coronavirus and very effective at preventing serious cases of the virus. The next step will be on Dec. 10 when the FDA will discuss approval for Pfizer and then Dec. 17 for Moderna. Karen Weintraub, health rep...

The two leading vaccine candidates are using technology that has never been approved in a commercial vaccine before. They both use messenger RNA to direct human cells to manufacture the spike protein found on the coronavirus. While this technology has been in development for two decades, the latest vaccines prove the science is sound and could change the way future vaccines are made. Karen Weintra...